pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Jul 1·1 min read
save

Ebola and Marburg outbreaks highlight need for pathogen-agnostic diagnostics

Jul 1, 2026·read at STAT ↗Negative

The authors describe a current Bundibugyo Ebola outbreak affecting the Democratic Republic of Congo and Uganda, which has resulted in more than 1,300 confirmed cases and over 375 deaths.

While the lack of licensed vaccines and treatments for this Ebola species draws attention, they argue that the most critical shortfall is the inability to quickly and reliably identify the virus on the ground.

Existing diagnostic tools, such as GeneXpert assays, were designed for Zaire ebolavirus and therefore miss other species, delaying response measures.

Kuppalli and Mbala call for a shift toward diagnostic platforms that can detect a wide range of pathogens without needing virus‑specific tests, a change they see as essential for future pandemic preparedness.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Opinion: What Ebola and Marburg are teaching us about the next pandemic”

read at STAT ↗
1,471 words · retrieved Jul 1
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
CYCLEUltragenyx Pharmaceutical Inc.
topics
Diagnostics Company9Vaccines4Infectious Disease3Pulmonology3Psychiatry & CNSRare Disease

related stories

  • 18h agoNovartis may cut around 130 in Switzerland while relocating biologics productionBioSpace
  • Jul 1FDA says Zyn can market its pouches as safer than cigarettesSTAT
  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • May 13Opinion: The hantavirus is a wake-up call. Will the Trump administration answer it?STAT
  • Aug 27FDA Approves First Oral Drug Indicated to Treat Dermatomyositis in Adultsfda press